Catalog » Browse by Author: S » Jerry Stahl
Jerry Stahl is the author of ten books, including the bestsellers Permanent Midnight, a memoir, and the novel I, Fatty. His journalism has appeared in Esquire, the New York Times, Vice, the Believer, and a variety of other publications. He has written extensively for film and television, including Hemingway & Gellhorn, which earned a Writers Guild Award nomination, CSI, and Escape at Dannemora, for which he received an Emmy nomination. Nein, Nein, Nein! is his latest book.
For a limited time, receive paperback copies of all books currently in our Drug Chronicles series (The Nicotine Chronicles, The Marijuana Chronicles, The Heroin Chronicles, The Speed Chronicles, and The Cocaine Chronicles) for $40, plus shipping!
The latest entry in the Akashic Drug Chronicles Series. Heroin has long been understood as the most “literary” of narcotics, and this collection will, for better and worse, have tremendous pop cultural appeal.
A guided group tour to concentration camps in Poland and Germany allows Stahl to confront personal and historical demons with both deep despair and savage humor.
Order on Bookshop
Order on Barnes & Noble
Order on Amazon
THIS PAGE IS FOR THE PAPERBACK EDITION OF NEIN, NEIN, NEIN!; IF YOU’RE LOOKING TO PURCHASE A HARDCOVER COPY, PLEASE CLICK HERE.
A guided group tour to concentration camps in Poland and Germany allows Stahl to confront personal and historical demons with both deep despair and savage humor
Buy on Bookshop
Buy on Amazon
Buy on Barnes & Noble
The best fiction anthology of cocaine-themed tales to blow through in years, featuring all-new stories from Susan Straight, Lee Child, Jerry Stahl, Ken Bruen, Laura Lippman, Bill Moody, Nina Revoyr, and many more.
Lee Child recruits Joyce Carol Oates, Jonathan Ames, Cara Black, and others to reveal nicotine’s scintillating alter egos.
*While supplies last, books ordered through the website will include a bookplate SIGNED by Lee Child!
Following the international success of the Noir Series, this volume marks the launch of a new drug-based sister series.